Category

Covid-19
This article was originally published on The Limbic Patients with blood cancer – including leukaemia, myeloma, and lymphoma – experience higher psychological distress from risk of COVID-19 infection and unmet needs, finds new research Over a year into the pandemic, we have all felt the effects at this point. But the disruptions and stress haven’t...
Continue Reading
Patients with blood cancer – including leukaemia, myeloma, and lymphoma – experience higher psychological distress from risk of COVID-19 infection and unmet needs, finds new research Over a year into the pandemic, we have all felt the effects at this point. But the disruptions and stress haven’t been spread evenly across the population and the...
Continue Reading
Dear Colleagues On behalf of Myeloma Australia’s Medical and Scientific Advisory Group (MSAG) please find below our article of the week and the current IMS COVID-19 vaccination guidelines. Association of Osteonecrosis of the Jaw With Zoledronic Acid Treatment for Bone Metastases in Patients With CancerVan Poznak, Unger, Darke, Moinpour, Bagramian, Schubert, Hansen, Floyd, Dakhil, Lew, Wade, Fisch, Henry,...
Continue Reading
This article was originally posted on Docwirenews According to new data published in Blood, patients with multiple myeloma (MM) who are hospitalized for COVID-19 infection face higher mortality compared with patients without MM, with age, disease status, and renal involvement serving as predictors of worse outcomes. MM is a hematological cancer of the plasma cells, particularly within bone...
Continue Reading
This article was originally published on Multiple Myeloma Today ABSTRACT BACKGROUND: Patients with hematological malignancies (HM), including multiple myeloma (MM), frequently suffer from immune deficiency-associated infectious complications because of both the disease and the treatment. Alarming results from China and the UK confirm the vulnerability of HM patients to severe acute respiratory syndrome coronavirus 2...
Continue Reading
This article was originally published on Cancer Therapy Advisor As the coronavirus disease 2019 (COVID-19) pandemic evolves into subsequent waves in many parts of the world, there are many outstanding questions about the outcomes of infection for patients with multiple myeloma, specifically around the severity of outcomes, prognostic factors, and the effect of different treatments....
Continue Reading
This article was originally published on CBC ‘We still had that sense of community happening out there anyway’ Small but mighty groups of those with multiple myeloma along with their loved ones hit the streets of Halifax and beyond this weekend to raise awareness and funds. They were together, but apart, due to the ongoing pandemic. Julie...
Continue Reading
This article was originally published by Cancer Therapy Advisor In the COVID-19 era, oncologists have had to reimagine routine cancer care and follow-up care, especially for patients who are immunocompromised. Among the top priorities: finding the right balance between high-quality cancer treatment and limiting patients’ exposure to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). For...
Continue Reading

Floor 7, 90 The Terrace
Wellington Central
New Zealand